TY - JOUR
T1 - Expanding nature's small molecule diversity via in vitro biosynthetic pathway engineering
AU - Kwon, Seok Joon
AU - Mora-Pale, Mauricio
AU - Lee, Moo Yeal
AU - Dordick, Jonathan S.
PY - 2012/4
Y1 - 2012/4
N2 - The enormous pool of chemical diversity found in nature serves as an excellent inventory for accessing biologically active compounds. This chemical inventory, primarily found in microorganisms and plants, is generated by a broad range of enzymatic pathways under precise genetic and protein-level control. In vitro pathway reconstruction can be used to characterize individual pathway enzymes, identify pathway intermediates, and gain an increased understanding of how pathways can be manipulated to generate natural product analogs. Moreover, through in vitro approaches, it is possible to achieve a diversification that is not restricted by toxicity, limited availability of intracellular precursors, or preconceived (by nature) regulatory controls. Additionally, combinatorial biosynthesis and high-throughput techniques can be used to generate both known natural products and analogs that would not likely be generated naturally. This current opinion review will focus on recent advances made in performing in vitro pathway-driven natural product diversification and opportunities for exploiting this approach for elucidating and entering this new chemical biology space.
AB - The enormous pool of chemical diversity found in nature serves as an excellent inventory for accessing biologically active compounds. This chemical inventory, primarily found in microorganisms and plants, is generated by a broad range of enzymatic pathways under precise genetic and protein-level control. In vitro pathway reconstruction can be used to characterize individual pathway enzymes, identify pathway intermediates, and gain an increased understanding of how pathways can be manipulated to generate natural product analogs. Moreover, through in vitro approaches, it is possible to achieve a diversification that is not restricted by toxicity, limited availability of intracellular precursors, or preconceived (by nature) regulatory controls. Additionally, combinatorial biosynthesis and high-throughput techniques can be used to generate both known natural products and analogs that would not likely be generated naturally. This current opinion review will focus on recent advances made in performing in vitro pathway-driven natural product diversification and opportunities for exploiting this approach for elucidating and entering this new chemical biology space.
UR - http://www.scopus.com/inward/record.url?scp=84862827529&partnerID=8YFLogxK
U2 - 10.1016/j.cbpa.2012.02.001
DO - 10.1016/j.cbpa.2012.02.001
M3 - Review article
C2 - 22397884
AN - SCOPUS:84862827529
SN - 1367-5931
VL - 16
SP - 186
EP - 195
JO - Current Opinion in Chemical Biology
JF - Current Opinion in Chemical Biology
IS - 1-2
ER -